Ascendiant Capital Markets Comments on Aemetis Q3 Earnings

Key Points

• Ascendiant Capital Markets raised its Q3 2026 EPS estimate for Aemetis to a loss of $0.18 per share from a previous estimate of $0.22, while maintaining a “Buy” rating and $22 price target.
• Aemetis’ latest quarterly results beat earnings expectations, reporting a $0.13-per-share loss versus the consensus loss of $0.29, although revenue of $62.7 million fell short of the $67.69 million estimate.
• Analyst sentiment remains mixed, with one Buy and one Sell rating producing an overall “Hold” consensus and an average price target of $11.88; institutional investors own 27.02% of the company.

Aemetis, Inc (NASDAQ:AMTX - Free Report) - Investment analysts at Ascendiant Capital Markets lifted their Q3 2026 earnings per share (EPS) estimates for shares of Aemetis in a note issued to investors on Wednesday, August 19th. Ascendiant Capital Markets analyst E. Woo now expects that the specialty chemicals company will post earnings of ($0.18) per share for the quarter, up from their previous forecast of ($0.22). Ascendiant Capital Markets has a "Buy" rating and a $22.00 price target on the stock. The consensus estimate for Aemetis' current full-year earnings is ($0.98) per share. Ascendiant Capital Markets also issued estimates for Aemetis' Q4 2026 earnings at ($0.19) EPS, FY2026 earnings at ($0.85) EPS, Q1 2027 earnings at ($0.16) EPS, Q2 2027 earnings at ($0.14) EPS, Q3 2027 earnings at ($0.12) EPS, Q4 2027 earnings at ($0.10) EPS and FY2027 earnings at ($0.52) EPS.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.16. The company had revenue of $62.70 million for the quarter, compared to analysts' expectations of $67.69 million.

Other analysts have also issued reports about the stock. Weiss Ratings restated a "sell (e+)" rating on shares of Aemetis in a research note on Friday, July 17th. Wall Street Zen upgraded shares of Aemetis from a "sell" rating to a "hold" rating in a research note on Saturday. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $11.88.

Aemetis Stock Performance

Shares of AMTX opened at $1.89 on Tuesday. Aemetis has a 1 year low of $1.30 and a 1 year high of $3.80. The stock has a market capitalization of $136.40 million, a PE ratio of -2.08 and a beta of 1.48. The stock has a 50-day simple moving average of $1.70 and a 200-day simple moving average of $2.08.

Institutional Trading of Aemetis

Hedge funds and other institutional investors have recently bought and sold shares of the business. Royal Bank of Canada lifted its holdings in Aemetis by 10,632.5% during the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company's stock worth $28,000 after buying an additional 8,825 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in shares of Aemetis in the 1st quarter valued at about $33,000. Creative Planning purchased a new position in shares of Aemetis in the 2nd quarter valued at about $30,000. Prairiewood Capital LLC acquired a new stake in shares of Aemetis during the 1st quarter worth about $47,000. Finally, Engineers Gate Manager LP acquired a new stake in shares of Aemetis during the 2nd quarter worth about $42,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source